Integrative Genome-Wide DNA Methylation and Gene Expression Analysis Reveals Biological and Clinical Insights In Adult Acute Lymphoblastic Leukemia

Detaylı Bibliyografya
Asıl Yazarlar:	Geng, H, Neuberg, D, Paietta, E, Deng, X, Li, Y, Xin, Y, Racevskis, J, Ketterling, R, Richards, S, Tallman, MS, Rowe, J, Litzow, MR, Elemento, O, Melnick, A
Materyal Türü:	Conference item
Baskı/Yayın Bilgisi:	2010

Integrative Genome Wide DNA Methylation and Gene Expression Analysis Reveals Biological and Clinical Insights In Adult Acute Lymphoblastic Leukemia
Yazar:: Geng, H, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemia.
Yazar:: Geng, H, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemia
Yazar:: Geng, H, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993).
Yazar:: Marks, D, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia
Yazar:: Moorman, A, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Outcome in Philadelphia Chromosome Positive (Ph plus ) Adult ALL Patients (Pts) May Be More Determined by CD25 Expression Than by Ph Status Per Se
Yazar:: Paietta, E, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Outcome of 1,229 Adult Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia (B-ALL) Patients (pts) From the International UKALLXII/E2993 Trial: No Difference In Results Between B Cell Immunophenotypic Subgroups
Yazar:: Lrrzow, MR, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Implications for the Use of Monoclonal Antibodies in Future Adult ALL Trials: Analysis of Antigen Expression in 505 B-Lineage (B-Lin) ALL Patients (pts) on the MRC UKALLXII/ECOG2993 Intergroup Trial.
Yazar:: Paietta, E, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Imatinib Significantly Enhances Long-Term Outcomes In Philadelphia Positive Acute Lymphoblastic Leukaemia; Final Results of the UKALLXII/ECOG2993 Trial
Yazar:: Fielding, A, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Imatinib Significantly Enhances Long Term Outcomes In Philadelphia Positive Acute Lymphoblastic Leukaemia, Final Results of the UKALLXII/ECOG2993 Trial
Yazar:: Fielding, A, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Standard Consolidation/Maintenance Chemotherapy Is Consistently Superior to a Single Autologous Transplant for Adult Patients with Acute Lymphoblastic Leukemia: Results of the International ALL Trial (MRC UKALL XII/ECOG E2993).
Yazar:: Rowe, J, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia.
Yazar:: Fielding, A, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Adult patients with acute lymphoblastic leukemia (ALL) and central nervous system (CNS) leukemia at diagnosis may attain durable complete remissions (CR). Results from the international ALL trial (MRC UKALL-XII/ECOG E2993)
Yazar:: Lazarus, H, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL) Results From the International MRC/ECOG Trial
Yazar:: Sive, J, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL): Results From the International MRC/ECOG Trial
Yazar:: Sive, J, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study.
Yazar:: Fielding, A, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993.
Yazar:: Lazarus, H, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Recent advances in the biology and treatment of B-cell acute lymphoblastic leukemia
Yazar:: Hefazi M, ve diğerleri
Baskı/Yayın Bilgisi: (2018-09-01)

Induction therapy for adults with acute lymphoblastic leukemia (ALL): Results of nearly 1,400 patients from the international ALL trial (MRC UKALL XII/ECOG E2993).
Yazar:: Rowe, J, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Spotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives [Erratum]
Yazar:: Anagnostou T, ve diğerleri
Baskı/Yayın Bilgisi: (2018-04-01)

The real world of acute lymphoblastic leukemia
Yazar:: Mark R. Litzow
Baskı/Yayın Bilgisi: (2024-09-01)

Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993.
Yazar:: Rowe, J, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukaemia
Yazar:: Moorman, A, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII/ECOG E2993 protocol.
Yazar:: Mansour, MR, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukaemia (ALL): Analysis of cytogenetic data from 1,235 patients on the medical research council (MRC) UKALLXII/Eastern cooperative oncology group (ECOG) 2993 trial.
Yazar:: Moorman, A, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial.
Yazar:: Moorman, A, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993.
Yazar:: Fielding, A, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Delays in Post-Remission Chemotherapy for Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia are Associated with Inferior Outcomes in Patients who Undergo Allogeneic Transplant: An Analysis from ECOG 2993/MRC UK ALLXII.
Yazar:: Kumar, A, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial.
Yazar:: Sive, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Outcome of 1,229 Adult Philadelphia Chromosome Negative B Acute Lyrnphoblastic Leukemia (B ALL) Patients (pts) From the International UKALLXII/E2993 Trial No Difference In Results Between B Cell Immuno phenotypic Subgroups
Yazar:: Lrrzow, MR, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993).
Yazar:: Goldstone, A, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

High hyperdiploidy among adolescents and adults with acute lymphoblastic leukaemia (ALL): cytogenetic features, clinical characteristics and outcome.
Yazar:: Chilton, L, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

High hyperdiploidy among adolescents and adults with acute lymphoblastic leukaemia (ALL): cytogenetic features, clinical characteristics and outcome
Yazar:: Chilton, L, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

High hyperdiploidy among adolescents and adults with acute lymphoblastic leukaemia (ALL): Cytogenetic features, clinical characteristics and outcome
Yazar:: Chilton, L, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Extramedullary acute myeloid leukemia presenting in young adults demonstrates sensitivity to high-dose anthracycline: a subset analysis from ECOG-ACRIN 1900
Yazar:: Hugo F. Fernandez, ve diğerleri
Baskı/Yayın Bilgisi: (2019-04-01)

At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII/ECOG E2993 trial
Yazar:: Ganzel, C, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Integrative Genome-Wide DNA Methylation and Gene Expression Analysis Reveals Biological and Clinical Insights In Adult Acute Lymphoblastic Leukemia

Benzer Materyaller

Benzer Materyaller